Cargando…
Incorporation of real-world data to a clinical trial: use of external controls
As real-world data (RWD) becomes more available and the methodology for handling RWD evolves, the use of RWD in drug development and drug approval is drawing interest. One of the ways RWD can be applied to a clinical trial is using an external control, a cohort of patients established separately ser...
Autores principales: | Kim, Tae-Eun, Park, Sang-In, Shin, Kwang-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Clinical Pharmacology and Therapeutics
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532857/ https://www.ncbi.nlm.nih.gov/pubmed/36247745 http://dx.doi.org/10.12793/tcp.2022.30.e14 |
Ejemplares similares
-
Application of Real-World Data to External Control Groups in Oncology Clinical Trial Drug Development
por: Yap, Timothy A., et al.
Publicado: (2022) -
Unit information prior for incorporating real-world evidence into
randomized controlled trials
por: Zhang, Hengtao, et al.
Publicado: (2023) -
Emulating Control Arms for Cancer Clinical Trials Using External Cohorts Created From Electronic Health Record‐Derived Real‐World Data
por: Tan, Katherine, et al.
Publicado: (2021) -
Real-world data on the survival outcome of patients with newly diagnosed Waldenström macroglobulinemia
por: Cho, Jang Ho, et al.
Publicado: (2021) -
Clinical Application of Next-Generation Sequencing in Patients With Breast Cancer: Real-World Data
por: Suh, Koung Jin, et al.
Publicado: (2022)